Daniel Chastain

Infectious diseases pharmacist | Clinical Associate Professor, UGA College of Pharmacy

[Andrés Henao, MD, PhD @andhen25]

Excited to announce our new Seminar on Leprosy just published online in @TheLancet! 🌍 @CUDeptMedicine
This multicontinental collaboration provides an update on key public health & clinical aspects of this curable yet stigmatized granulomatous disease

https://t.co/GkWakEJQ1C

[Chris Bland @blandman19]

Super job by my @UGAPharmacy colleague @DBChastain leading this review (FREE Open Access): Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review https://t.co/Npm8GURWiB

[Timothy Li @drtimothyli]

Suggested investigation of suspected immunosuppression*

*Also: recurrent deep abscesses, chronic diarrhoea with weight loss, recurring infections, infection requiring prolonged antibiotic therapy, persistent rash (particularly without recent antibiotic use).

https://t.co/TXgFJfrfAx

[Daniel Chastain @DBChastain]

Thankful to have worked with @andhen25 and @GRThompsonMD in highlighting the low rates and inconsistent prescribing of PJP prophylaxis for patients on glucocorticoids ≥2 weeks in @CIDJournal

[Clinical Infectious Diseases @CIDJournal]

Glucocorticoids, Concomitant Immunosuppression, and PJP Prophylaxis Among U.S. Adults

✅ Just Accepted
✍️ @DBChastain
🔗 https://t.co/yP9pnsaJ54

[P. Brandon Bookstaver @BBookstaver_USC]

The @AJHPOfficial ID themed issue was just released and we're (@stoverkr & I) excited to slowly share a brief synopsis of the included articles in this thread.

First, a link to the full issue to browse the TOC is here: https://t.co/qaMOhe1ERE
#idxposts @ASHPOfficial

[P. Brandon Bookstaver @BBookstaver_USC]

Thanks @ASP_PharmD
Here's a direct link to the ID themed issue:

https://t.co/qaMOhe1ERE

I'll try and provide a brief recap on the full edition over @X soon!

@AJHPOfficial @AJHPOfficial @stoverkr

[Daniel Chastain @DBChastain]

Great collab w/ @UGAPharmacy students Meg George & Tonisha Gaitor, @andhen25, and @DavidCluck2, examining climate change's impact on fungal infections, incl. increased virulence, resistance, & emerging pathogens! Thanks @TAInfDis! https://t.co/HAO2yOs5dK

[Therapeutic Advances in Infectious Disease @TAInfDis]

🌍🔥 Climate change is fueling the rise of fungal infections! Warmer temps, extreme weather & shifting ecosystems are making fungi more virulent & drug-resistant. With rising host susceptibility, the threat is growing.
https://t.co/QQznCAHSRN

[Chris Bland @blandman19]

Good discussion on pros and cons of potentially shortening treatment duration for candidemia by @UGAPharmacy faculty @DBChastain. Still awaiting more data to make informed decisions on appropriate DOT. #ashp24

[Andrés Henao, MD, PhD @andhen25]

Inspired on our recent trips to Peru and Zimbabwe

We have so much to learn from our Global South colleagues

#GlobalHealth

@CUDeptMedicine @E_Stenehjem @paimadhu

[Daniel Chastain @DBChastain]

@IDstewardship maybe this will help - https://t.co/HQ9c988qLo

[Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship]

https://t.co/dJiXyZesA9 in @AJHPOfficial

No abstract available, not open access 😢

[Kayla Stover @stoverkr]

Looking for a PGY2 ID residency (or CC, or Peds)? Come see @UMMCPharmacy at either the SNPhA x ACCP showcase this week or at ASHP Midyear! All PGY2 programs will be at PPS!

[Joseph Sassine @JosephSassineMD]

Our large database analysis @TriNetX of viral and fungal infections after CAR T cell therapy is out now at @CMIJournal! With @Emily_Siegrist @andhen25 @RitaWilsonDib1 @joseandres2910 @DBChastain @chiayuchiuID et al.
@OUCollegeofMed #TxID #lymsm #mmsm
🧵

https://t.co/dDERJWuR0C

[Andrés Henao, MD, PhD @andhen25]

My beloved Cali, Colombia is hosting the 16th meeting of the Conference of the Parties to the Convention on Biological Diversity 🌿 🦠🌍

@UNBiodiversity is spotlighting how protecting our planet's biodiversity can help prevent diseases

#COP16 #GlobalHealth @CUDeptMedicine

[Daniel Chastain @DBChastain]

Thanks, @hallpharms! It was a lot of fun putting these slides together and highlighting all the fantastic work being done with SAB.

[Daniel Chastain @DBChastain]

@bryan_p_white Important work by @bryan_p_white describing the variability in managing SAB (https://t.co/a7II8vEKRu)

[Daniel Chastain @DBChastain]

What a fantastic session with @andhen25 and @bryan_p_white! Appreciate @IDWeekmtg for the opportunity to watch virtually.

[Therapeutic Advances in Infectious Disease @TAInfDis]

So excited to hear from our super ⭐️ Editor in Chief @andhen25 about optimal therapy for invasive Candidiasis 🍄 #IDWeek2024

[Daniel Chastain @DBChastain]

Thank you so much @patricia_rdz_z! Appreciate you sharing the presentation.

[Patricia Rodriguez Zulueta @patricia_rdz_z]

#IDWeek2024 Biterapia en bacteriemia por Estafilococo aureus, en Camera 1 y Camera 2 origen endovascular está subrepresentado .8-39% no responden a monoterapia. En quien considerarla riesgo de Bacteremia persistente estratificar pacientes . Great talk @DBChastain

[Daniel Chastain @DBChastain]

You're the best @stoverkr! Thank you so much for all your support!

[Kayla Stover @stoverkr]

Kudos to #IDWeek2024 for providing the hybrid meeting option so I could watch this 🔥🔥 session with @DBChastain and moderated by @blandman19 on the way home.

[Daniel Chastain @DBChastain]

Well done, @ferraz_md! Congratulations!

[Andrés Henao, MD, PhD @andhen25]

A huge shoutout to the talented @ferraz_md for her inspiring poster and research on candidemia mortality differences by species at @IDWeekmtg 🌟

Your work is crucial in advancing our understanding and treatment of this serious infection. Bravo! 👏🦠

@CUDivofID @CUAnschutz

[Michael Calderwood, MD, MPH @CalderwoodMD]

I love these two slides on the evidence for combination therapy in persistent MRSA and MSSA bacteremia. References in footer of each slide. #IDWeek2024